These Stocks Could Gain From Venezuela’s Upheaval

DraftKings’ bulls were thrown an unexpected curveball, but this new competition doesn’t carry the same brand-name cache. After years of development, Recursion Pharmaceuticals’ AI-powered drug discovery technology should finally, firmly start proving its true value.

Bloomberg Television brings you the latest news and analysis leading up to the final minutes and seconds before and after the closing bell on Wall Street. Today’s guests are CBOE Global Markets’s Mandy Xu, Blackrock’s Jon Diorio, Wells Fargo’s Timna Tanner, Ro’s Zach Reitano, PIMCO’s Jerome Schneider, Barclays’ Venu Krishna, Wedbush Securities’ Matt Bryson, M12’s Cheryl Cheng, Lightshed Partners’ Walter Piecyk, Siri’s Dag Kittlaus, Russell Reynolds Associates’ Ty Wiggins.

Several top-rated Zacks stocks are standing out from a variety of sectors after exceeding Q4 EPS expectations on Monday.